Let’s talk frankly.
If it’s true that biotech in the next thirty years will have a similar impact to what ICT has been provided in the last thirty, then, one can be pretty sure that no company have enough resources to provide all solutions. That is why traditional firms in the 21th century have to disappear, leaving space to the galvanizing message of platforms able to redefine entire markets.
Our platform aims at providing life scientists with delightful and meaningful research experience.
We do this by bundling available components from wasteful supply chains, and by connecting untapped human value in crafting the next generation of lab automation platform.
In biology and clinical laboratories, hours of manual work are a compulsory part of the experiments and diagnostic protocols. In the past decades, a big effort has been done to develop machines (e.g. pipetting robots) that would automate some of the recurrent tasks in a molecular biology lab (pipetting, cell culture, analysis, labelling and tracking of samples etc.).
Despite the effort, these machines are: large sized, task-specific, difficult to use, and most importantly, extremely expensive. In fact, there is a very fragmented market of lab automation that is currently under served. The only way to address those kind of long tail markets is to build infrastructural components and interfaces that enable and empower end users, businesses and professionalized entities to recombine, reconfigure and customize these bits and pieces. We want to serve customers’ delight and appreciation by providing custom low to medium throughput solutions.
We want to offer the world a full stack of lab automation components that can be scaled up as needed. Join us.